AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...

The S&P 500 Index ($SPX) (SPY) today is down -0.97%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.69%, and the ...

The Magnificent Seven stocks are under pressure today, weighing on the overall market. Tesla ( TSLA) and Nvidia ( NVDA) are ...

The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the ...

Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

If you’re eyeing Pfizer stock and wondering what’s next, you’re definitely not alone. The last few years have been a roller coaster for this healthcare heavyweight, and plenty of investors are ...

Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, according to a new study that comes as the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming ...

Trump's remark, made during a White House event on drug pricing, instantly turned Novo Nordisk into a lightning rod for the administration's push to lower costs. The company confirmed discussions with ...

Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder cancer (NMIBC) suggest the PD-L1 inhibitor measures up to Pfizer’s PD-1 ...